Literature DB >> 12417341

Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords--screening by molecular indexing and subsequent cDNA microarray analysis.

Shinsuke Ishigaki1, Jun ichi Niwa, Yoshio Ando, Tsuyoshi Yoshihara, Ko ichi Sawada, Manabu Doyu, Masahiko Yamamoto, Kikuya Kato, Yoshihisa Yotsumoto, Gen Sobue.   

Abstract

To analyze the genes related to the pathophysiology of sporadic amyotrophic lateral sclerosis (SALS) we performed gene profiling of SALS spinal cords using molecular indexing combined with cDNA microarray. Eighty-four fragments were cloned in the first screening procedure with molecular indexing. Subsequent quantitative microarray screening revealed 11 genes which were differentially expressed in SALS. Real-time RT-PCR verified that the expression level of the following six genes was altered in SALS: dorfin, metallothionein-3, 30 kDa TATA-binding protein-associated factor, neugrin, ubiquitin-like protein 5 and macrophage-inhibiting factor-related protein-8. These results indicated that genes associated with the ubiquitin-proteasome system, oxidative toxicity, transcription, neuronal differentiation and inflammation might be involved in the pathogenesis of SALS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12417341     DOI: 10.1016/s0014-5793(02)03546-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  17 in total

Review 1.  Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.

Authors:  Ashok N Hegde; Sudarshan C Upadhya
Journal:  Biochim Biophys Acta       Date:  2010-08-03

Review 2.  Current and future directions in genomics of amyotrophic lateral sclerosis.

Authors:  John Ravits; Bryan J Traynor
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-08       Impact factor: 1.784

3.  Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model.

Authors:  Caroline Rouaux; Irina Panteleeva; Frédérique René; Jose-Luis Gonzalez de Aguilar; Andoni Echaniz-Laguna; Luc Dupuis; Yannick Menger; Anne-Laurence Boutillier; Jean-Philippe Loeffler
Journal:  J Neurosci       Date:  2007-05-23       Impact factor: 6.167

4.  The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosis.

Authors:  Hirotaka Tanaka; Masamitsu Shimazawa; Masataka Kimura; Masafumi Takata; Kazuhiro Tsuruma; Mitsunori Yamada; Hitoshi Takahashi; Isao Hozumi; Jun-ichi Niwa; Yohei Iguchi; Takeshi Nikawa; Gen Sobue; Takashi Inuzuka; Hideaki Hara
Journal:  Sci Rep       Date:  2012-08-13       Impact factor: 4.379

5.  Phosphatase and tensin homologue/protein kinase B pathway linked to motor neuron survival in human superoxide dismutase 1-related amyotrophic lateral sclerosis.

Authors:  Janine Kirby; Ke Ning; Laura Ferraiuolo; Paul R Heath; Azza Ismail; Su-Wei Kuo; Chiara F Valori; Laura Cox; Basil Sharrack; Stephen B Wharton; Paul G Ince; Pamela J Shaw; Mimoun Azzouz
Journal:  Brain       Date:  2011-01-12       Impact factor: 13.501

6.  Can transcriptomics cut the gordian knot of amyotrophic lateral sclerosis?

Authors:  Alexandre Henriques; Jose-Luis Gonzalez De Aguilar
Journal:  Curr Genomics       Date:  2011-11       Impact factor: 2.236

7.  Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis.

Authors:  Cristina Cheroni; Marianna Marino; Massimo Tortarolo; Pietro Veglianese; Silvia De Biasi; Elena Fontana; Laura Vitellaro Zuccarello; Christa J Maynard; Nico P Dantuma; Caterina Bendotti
Journal:  Hum Mol Genet       Date:  2008-09-29       Impact factor: 6.150

8.  Identification of epigenetically altered genes in sporadic amyotrophic lateral sclerosis.

Authors:  Claudia Figueroa-Romero; Junguk Hur; Diane E Bender; Colin E Delaney; Michael D Cataldo; Andrea L Smith; Raymond Yung; Douglas M Ruden; Brian C Callaghan; Eva L Feldman
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.752

9.  Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS).

Authors:  Allison S Limpert; Margrith E Mattmann; Nicholas D P Cosford
Journal:  Beilstein J Org Chem       Date:  2013-04-15       Impact factor: 2.883

10.  Identification of pharmacological targets in amyotrophic lateral sclerosis through genomic analysis of deregulated genes and pathways.

Authors:  Sabrina Paratore; Salvatore Pezzino; Sebastiano Cavallaro
Journal:  Curr Genomics       Date:  2012-06       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.